Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Vikram Udani

Neurological Surgery San Diego, CA Medical Doctor

NPI 1093959108 CMS profile 322123

11199 Sorrento Valley Rd Ste 203, San Diego, CA 92121

Open in the dashboard

General payments

$1,102,964

324 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Vikram Udani of San Diego, CA is reported in the CMS Open Payments database as having received $1,102,964 across 324 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $178,726 50
2024 General $146,773 58
2023 General $182,048 69
2022 General $167,510 53
2021 General $149,129 23
2020 General $155,534 40
2019 General $123,244 31

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Vikram Udani
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Vikram Udani were reported at $178,726. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Vikram Udani Neurological Surgery median Middle half National median
2019 $123,244 $582 $138–$3,006 $163
2020 $155,534 $294 $76–$2,174 $114
2021 $149,129 $387 $105–$2,432 $132
2022 $167,510 $542 $139–$2,989 $149
2023 $182,048 $534 $145–$2,697 $160
2024 $146,773 $574 $155–$3,046 $164
2025 $178,726 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Globus Medical, Inc. $839,117 40 payments
  2. Precision Spine, Inc. $194,753 57 payments
  3. Aurora Spine, Inc. $23,444 4 payments
  4. Kyocera Medical Technologies, Inc. $16,000 2 payments
  5. Acumed LLC $8,328 19 payments
  6. Alphatec Spine, Inc $6,497 10 payments
  7. Intrinsic Therapeutics $3,248 15 payments
  8. Osteomed LLC $2,304 10 payments
  9. Spineart USA Inc $1,500 1 payment
  10. Nevro Corp. $1,270 76 payments
  11. Other $6,501 90 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $994,246 50 payments
  2. Consulting Fee $93,693 46 payments
  3. Food and Beverage $10,156 218 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,975 2 payments
  5. Travel and Lodging $1,552 5 payments
  6. Education $343 3 payments
Products named General payments · program years 2019–2025
  1. QUARTEX Spine $327,316 9 payments
  2. QUARTEX Spine/Spine Surgery $252,037 7 payments
  3. QUARTEX Spine/Spine Surgery $138,859 4 payments
  4. Reform Ti Modular Orthopedics $125,522 20 payments
  5. QUARTEX Spine/Joint $120,651 4 payments
  6. Reform Ti Modular Orthopedics $23,540 5 payments
  7. ZIP/SOLO-L $23,444 4 payments
  8. REFORM TI MODULAR Orthopedics $9,325 7 payments
  9. ACIF 2C SYSTEM $7,000 1 payment
  10. SLIMPLICITY HP $6,000 4 payments
  11. Other $65,574 265 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

96

Median for Neurosurgery: 83

Drug cost

$1,710

Median for Neurosurgery: $872

Branded share of claims

41.7%

Median for Neurosurgery: 16.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Tranexamic Acid Generic 14 $825
Cyclobenzaprine Hcl Generic 27 $308
Gabapentin Generic 15 $209
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 23 $204
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 17 $164

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 88 billing codes

Paid by Medicare

$270,261

Medicare's payments for the services billed

Medicare patients

514

Average age 77

Services billed

1,047

281 women, 233 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 69%
Diabetes 40%
Ischemic heart disease 37%
Depression 35%
Chronic kidney disease 32%
Heart failure 29%
Atrial fibrillation 25%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

324 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record